In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells

High-throughput screening was performed as a phenotypic screening on clinically relevant human mesenchymal stem cells to identify small molecules that affect stem cell fate. From a library of pharmacologically active small molecules, we identified kaempferol, which is a natural flavonol, with a high...

Full description

Bibliographic Details
Main Authors: Tetsuro Mazaki, Takashi Kitajima, Yasuyuki Shiozaki, Miwa Sato, Megumi Mino, Aki Yoshida, Mariko Nakamura, Yasuhiro Yoshida, Masato Tanaka, Toshifumi Ozaki, Akihiro Matsukawa, Yoshihiro Ito
Format: Article
Language:English
Published: Elsevier 2014-01-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464613002417
id doaj-0041d74b11cb4ee69bf2fd92f23ab1b6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Tetsuro Mazaki
Takashi Kitajima
Yasuyuki Shiozaki
Miwa Sato
Megumi Mino
Aki Yoshida
Mariko Nakamura
Yasuhiro Yoshida
Masato Tanaka
Toshifumi Ozaki
Akihiro Matsukawa
Yoshihiro Ito
spellingShingle Tetsuro Mazaki
Takashi Kitajima
Yasuyuki Shiozaki
Miwa Sato
Megumi Mino
Aki Yoshida
Mariko Nakamura
Yasuhiro Yoshida
Masato Tanaka
Toshifumi Ozaki
Akihiro Matsukawa
Yoshihiro Ito
In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
Journal of Functional Foods
Kaempferol
Ipriflavone
Flavonoids
High-throughput screening
Mesenchymal stem cell
Osteoporosis
author_facet Tetsuro Mazaki
Takashi Kitajima
Yasuyuki Shiozaki
Miwa Sato
Megumi Mino
Aki Yoshida
Mariko Nakamura
Yasuhiro Yoshida
Masato Tanaka
Toshifumi Ozaki
Akihiro Matsukawa
Yoshihiro Ito
author_sort Tetsuro Mazaki
title In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
title_short In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
title_full In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
title_fullStr In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
title_full_unstemmed In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
title_sort in vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cells
publisher Elsevier
series Journal of Functional Foods
issn 1756-4646
publishDate 2014-01-01
description High-throughput screening was performed as a phenotypic screening on clinically relevant human mesenchymal stem cells to identify small molecules that affect stem cell fate. From a library of pharmacologically active small molecules, we identified kaempferol, which is a natural flavonol, with a high osteogenic activity. Kaempferol achieved the highest levels of bone-specific markers among the chemicals tested in vitro. The osteogenic activity of kaempferol was the same as that of ipriflavone, which is a synthetic isoflavone, in ovariectomized mouse experiments. Considering that kaempferol is present in various foods such as vegetables and fruits, it will be useful as a new preventive medicine for osteoporosis.
topic Kaempferol
Ipriflavone
Flavonoids
High-throughput screening
Mesenchymal stem cell
Osteoporosis
url http://www.sciencedirect.com/science/article/pii/S1756464613002417
work_keys_str_mv AT tetsuromazaki invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT takashikitajima invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT yasuyukishiozaki invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT miwasato invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT megumimino invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT akiyoshida invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT marikonakamura invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT yasuhiroyoshida invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT masatotanaka invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT toshifumiozaki invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT akihiromatsukawa invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
AT yoshihiroito invitroandinvivoenhancedosteogenesisbykaempferolfoundbyahighthroughputassayusinghumanmesenchymalstromalcells
_version_ 1721501894757580800
spelling doaj-0041d74b11cb4ee69bf2fd92f23ab1b62021-04-29T04:41:46ZengElsevierJournal of Functional Foods1756-46462014-01-016241247In vitro and in vivo enhanced osteogenesis by kaempferol found by a high-throughput assay using human mesenchymal stromal cellsTetsuro Mazaki0Takashi Kitajima1Yasuyuki Shiozaki2Miwa Sato3Megumi Mino4Aki Yoshida5Mariko Nakamura6Yasuhiro Yoshida7Masato Tanaka8Toshifumi Ozaki9Akihiro Matsukawa10Yoshihiro Ito11Department of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan; Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanNano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako 351-0198, Japan; Molecular Ligand Biology Research Team, Chemical Genomics Research Group, Chemical Biology Department, RIKEN Advanced Science Institute, 2-1 Hirosawa, Wako 351-0198, JapanDepartment of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan; Department of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan; Department of Health and Welfare Program, Kibi International University Junior College, 8 Iga-machi, Takahashi, Okayama 716-8508, JapanDepartment of Biomaterials, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Orthopaedic Surgery, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanDepartment of Pathology and Experimental Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, JapanNano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako 351-0198, Japan; Molecular Ligand Biology Research Team, Chemical Genomics Research Group, Chemical Biology Department, RIKEN Advanced Science Institute, 2-1 Hirosawa, Wako 351-0198, Japan; Corresponding author at: Nano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako 351-0198, Japan. Tel.: +81 48 467 5809; fax: +81 48 467 9300.High-throughput screening was performed as a phenotypic screening on clinically relevant human mesenchymal stem cells to identify small molecules that affect stem cell fate. From a library of pharmacologically active small molecules, we identified kaempferol, which is a natural flavonol, with a high osteogenic activity. Kaempferol achieved the highest levels of bone-specific markers among the chemicals tested in vitro. The osteogenic activity of kaempferol was the same as that of ipriflavone, which is a synthetic isoflavone, in ovariectomized mouse experiments. Considering that kaempferol is present in various foods such as vegetables and fruits, it will be useful as a new preventive medicine for osteoporosis.http://www.sciencedirect.com/science/article/pii/S1756464613002417KaempferolIpriflavoneFlavonoidsHigh-throughput screeningMesenchymal stem cellOsteoporosis